Drug Shortage Report for MAR-ATORVASTATIN
Report ID | 127855 |
Drug Identification Number | 02454025 |
Brand name | MAR-ATORVASTATIN |
Common or Proper name | ATORVASTATIN |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | ATORVASTATIN |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 500 TABLET |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2020-11-06 |
Actual start date | 2020-11-06 |
Estimated end date | 2021-03-08 |
Actual end date | 2021-03-08 |
Shortage status | Resolved |
Updated date | 2021-03-09 |
Company comments | Business reasons |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-03-09 | English | Compare |
v5 | 2021-03-08 | French | Compare |
v4 | 2021-03-08 | English | Compare |
v3 | 2020-11-07 | English | Compare |
v2 | 2020-11-06 | French | Compare |
v1 | 2020-11-06 | English | Compare |
Showing 1 to 6 of 6